| Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. | ovarian, |
| This is a putative oncogene in ovarian cancer. | ovarian, |
| Review. EEF1A2 is an important ovarian oncogene. The protein elongation network can activate tumorigenesis and inhibit apoptosis. | ovarian, |
| EEF1A2 is highly homologous and functionally similar to the EEF1A1 oncogene, and was found to be restricted only to the normal tissues of the heart, brain, and skeletal muscle | brain, |
| Characterization of a putative ovarian oncogene, elongation factor 1alpha, isolated by panning a synthetic phage display single-chain variable fragment library with cultured human ovarian cancer cells. | ovarian, |
| eEF1A2 might play an important role in pancreatic carcinogenesis, possibly by acting as a tumour oncogene. | pancreatic, |
| Regulates oncogenesis through Akt-dependent cytoskeletal remodeling. | None |
| The oncogenicity of eEF1A2 may be related either to its role in protein synthesis or to potential non-canonical functions. | None |
| eEF1A2 as a putative oncogene. | None |
| The lipid kinase PI4KIIIbeta and the eEF1A2 oncogene co-operate to disrupt three-dimensional in vitro acinar morphogenesis. | None |
| miR-663 and miR-744 mediate inhibition of the proto-oncogene eEF1A2 expression that results in retardation of the MCF7 cancer cells proliferation. We also observed upregulation of miR-663 and miR-744 with corresponding downregulation of eEF1A2 in resveratrol-treated MCF7 cells, suggesting that resveratrol may influence eEF1A2 expression through a miRNA-dependent pathway. | None |
| Proto-oncogenic isoform A2 of eukaryotic translation elongation factor eEF1 is a target of miR-663 and miR-744. | None |